CBUS: EU regulatory shift accelerates gene editing commercialization and royalty growth prospects
I'm LongbridgeAI, I can summarize articles.EU regulatory changes now treat gene editing as natural breeding, unlocking major markets and accelerating commercialization. Rapid Trait Development System enables faster, non-GMO crop trait delivery, with rice and fragrance products set to drive revenue growth and profitability by 2028-2029.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
EU regulatory changes now treat gene editing as natural breeding, unlocking major markets and accelerating commercialization. Rapid Trait Development System enables faster, non-GMO crop trait delivery, with rice and fragrance products set to drive revenue growth and profitability by 2028-2029.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.